| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.007 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.008 |
| mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
| mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.008 |
| mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.009 |
| mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.009 |
| mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.009 |
| mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.009 |
| mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
| mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |